How anti-Müllerian hormone helps determine biological sex
Functional Analysis of the Anti-Müllerian Hormone as a Convergently Acquired Master Sex Determination Gene
This work looks at whether extra copies of the anti-Müllerian hormone gene can steer early development toward male pathways and may help explain some human differences in sex development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11325349 on NIH RePORTER |
What this research studies
From the patient perspective, researchers use stickleback fish to learn how copies of the anti-Müllerian hormone (Amh) gene were independently adopted as master sex-determining genes. They compare closely related species with different sex chromosomes, examine regulatory elements around Amh copies, and measure downstream gene activity during early development. Laboratory methods include genetic manipulation, molecular assays, and transcriptome analysis to map how Amh variants reshape the sex differentiation network. The team hopes these fish-based findings will shed light on genetic mechanisms behind human disorders of sexual development.
Who could benefit from this research
Good fit: This project does not enroll patients; its results may be most relevant to people with congenital differences in sex development (DSD).
Not a fit: People seeking immediate clinical treatment or expecting direct medical interventions should not expect to benefit from this laboratory-based fish genetics research.
Why it matters
Potential benefit: If successful, this work could clarify genetic causes of disorders of sexual development and guide future diagnostic or treatment research.
How similar studies have performed: Scientists have shown AMH influences male development in some species, but using independently evolved stickleback Amh copies to demonstrate a shared transcriptional response is a novel and less-tested approach.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: White, Michael Andrew — University of Georgia
- Study coordinator: White, Michael Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.